The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116711982 11671198 2 F 20160606 20151028 20160817 PER US-ASTRAZENECA-2015SF01442 ASTRAZENECA 0.00 M Y 81.60000 KG 20160818 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116711982 11671198 1 PS MOVANTIK NALOXEGOL OXALATE 1 Oral 204760 25 MG TABLET QD
116711982 11671198 2 SS ATENOLOL. ATENOLOL 1 Unknown U 0 50 MG BID
116711982 11671198 3 C AMLODIPINE AMLODIPINE BESYLATE 1 0 10 MG QD
116711982 11671198 4 C K-CITRATE 2 0 10 MG BID
116711982 11671198 5 C SIMVASTATIN. SIMVASTATIN 1 0 10 MG QD
116711982 11671198 6 C ALPRAZALOM 2 0 .5 MG BID
116711982 11671198 7 C CITROBENZOPRINE 2 0 10 MG Q8H
116711982 11671198 8 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 0 10 MG BID
116711982 11671198 9 C REMACAIDE 2 EVERY 2 MONTHS 0 INTRAVENOUS INFUSION
116711982 11671198 10 C METACAPURINE 2 0 50 MG QD
116711982 11671198 11 C MOM MAGNESIUM HYDROXIDE 1 0
116711982 11671198 12 C DULCOLAX NOS BISACODYL OR DOCUSATE SODIUM 1 0
116711982 11671198 13 C COLACE DOCUSATE SODIUM 1 0
116711982 11671198 14 C RELESTOR 2 Intravenous (not otherwise specified) 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116711982 11671198 1 Constipation
116711982 11671198 11 Laxative supportive care
116711982 11671198 12 Laxative supportive care
116711982 11671198 13 Laxative supportive care
116711982 11671198 14 Constipation

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
116711982 11671198 Abdominal pain upper
116711982 11671198 Back pain
116711982 11671198 Constipation
116711982 11671198 Myalgia
116711982 11671198 Neck pain
116711982 11671198 Nephrolithiasis
116711982 11671198 Pain

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116711982 11671198 1 20151009 0